B lymphocytes and Epstein–Barr virus: The lesson of post-transplant lymphoproliferative disorders
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 7 (2) , 96-101
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The role of Epstein–Barr virus in cancerExpert Opinion on Biological Therapy, 2006
- Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse ModelJournal of Virology, 2005
- Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell LinesJournal of Virology, 2005
- Post-Transplant Lymphoproliferative DisordersAnnual Review of Medicine, 2005
- B cells under influence: transformation of B cells by Epstein–Barr virusNature Reviews Immunology, 2003
- Epstein–Barr virus: Induction and control of cell transformationJournal of Cellular Physiology, 2003
- Identifying the patient at risk for post‐transplant lymphoproliferative disorderTransplant Infectious Disease, 2001
- Tonsillar memory B cells, latently infected with Epstein–Barr virus, express the restricted pattern of latent genes previously found only in Epstein–Barr virus-associated tumorsProceedings of the National Academy of Sciences, 2000
- Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed PatientsJournal of Experimental Medicine, 1999
- EBV Persistence in Memory B Cells In VivoImmunity, 1998